Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,115,243
+$6,115,243 QoQ
Shares Held
12,311
Ownership
0.005%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#431
of 1,705 holders
Holding Since
Mar 2021
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Derivatives in VRTX
reported options exposure · as of Mar 31, 2026CallValue
$4,465,400
CallShares
10,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026J. Goldman & Co LP holds $154,729,761 across 52 Biotechnology names. VRTX ranks #7 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | COGT |
Cogent Biosciences, Inc.
|
637,994 | $24,690,367 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
38,698 | $11,649,258 | |
| 3 | CAPR |
Capricor Therapeutics, Inc.
|
427,321 | $10,289,889 | |
| 4 | MGTX |
MeiraGTx Holdings plc
|
601,972 | $8,132,641 | |
| 5 | ARDX |
Ardelyx, Inc.
|
1,579,828 | $8,057,122 | |
| 6 | URGN |
UroGen Pharma Ltd.
|
212,775 | $7,830,120 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
12,311 | $6,115,243 | |
| 8 | ELVN |
Enliven Therapeutics, Inc.
|
112,129 | $5,690,546 |
All Filings in VRTX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,115,243 | 12,311 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,465,400 | 10,000 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $770,712 | 1,700 | Put | Sole | 2026-02-17 | |
| 2025-06-30 | $465,234 | 1,045 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $2,416,200 | 6,000 | Call | Sole | 2025-02-14 | |
| 2024-03-31 | $1,770,690 | 4,236 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,336,498 | 8,200 | Call | Sole | 2024-02-14 | |
| 2023-06-30 | $6,158,425 | 17,500 | Put | Sole | 2023-08-14 | |
| 2023-06-30 | $615,842 | 1,750 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $8,711,915 | 30,168 | Shares | Sole | 2023-02-14 | |
| 2022-12-31 | $15,882,900 | 55,000 | Call | Sole | 2023-02-14 | |
| 2022-03-31 | $3,123,810 | 11,970 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,155,535 | 5,262 | Shares | Sole | 2022-02-14 | |
| 2021-12-31 | $1,647,000 | 7,500 | Call | Sole | 2022-02-14 | |
| 2021-03-31 | $7,241,793 | 33,700 | Call | Sole | 2021-05-17 | |
| 2021-03-31 | $6,340,974 | 29,508 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||